Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target

The current SARS-CoV-2 pandemic is still threatening humankind. Despite first successes in vaccine development and approval, no antiviral treatment is available for COVID-19 patients. The success is further tarnished by the emergence and spreading of mutation variants of SARS-CoV-2, for which some v...

Descripción completa

Detalles Bibliográficos
Autores principales: Renz , Alina, Widerspick , Lina, Dräger , Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225150/
https://www.ncbi.nlm.nih.gov/pubmed/34073716
http://dx.doi.org/10.3390/genes12060796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225150/
https://www.ncbi.nlm.nih.gov/pubmed/34073716
http://dx.doi.org/10.3390/genes12060796

Ejemplares similares